Global Genotyping Assay Market Size By Product And Service (Reagents And Kits, Genotyping Services), By Technology (Microarrays, Polymerase Chain Reaction, Sequencing), By End-Use (Pharmacogenomics, Personalized Medicine And Diagnostics), By Geographic Scope And Forecast

Genotyping Assay Market Size And Forecast

Genotyping Assay Market size was valued at USD 17.2 Billion in 2023 and is projected to reach USD 80.4 Billion by 2030, growing at a CAGR of 20.1% from 2024 to 2030.

The increasing prevalence of genetic disorders, advancements in genomic research, increasing demand for biomarker discovery, and growing collaboration and partnerships between public and private institutions are key factors driving the market growth. Additionally, the growing adoption of genotyping in agriculture and animal breeding for the selection and identification of desirable traits, disease resistance, and improved productivity is further driving the demand for the method. The Global Genotyping Assay Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Genotyping Assay Market Definition

Genotyping assay is a laboratory method used for identifying and analyzing the genetic variants or polymorphisms in DNA. It involves detecting and characterizing specific genetic markers or mutations at particular locations throughout the genome. Single nucleotide polymorphisms (SNPs), copy number variations (CNVs), insertions/deletions (indels), and other forms of genetic changes can be detected using this technique. DNA extraction from a sample is often followed by amplifying particular target areas using techniques such as polymerase chain reaction (PCR) or hybridization-based approaches. The amplified DNA is subsequently analyzed using different technologies such as real-time PCR, microarrays, or next-generation sequencing (NGS) to detect the presence or absence of specific genetic variants.

Genotyping assays have applications in Genetic research, pharmacogenomics, clinical diagnostics, forensics, personalized medicine, agriculture, and animal breeding. They help to identify genetic risk factors for diseases, study the drug response and efficacy, understand evolutionary relationships and population genetics, diagnose genetic problems, and make informed breeding decisions. The technique provides valuable information for clinicians, researchers, and healthcare professionals to optimize drug therapies, personalize medical treatments, and develop targeted therapies based on the individual genetic profile.

Global Genotyping Assay Market Overview

The growing prevalence of genetic conditions such as cardiovascular diseases, cancer, and neurological disorders drives the market’s growth. Genotyping tests are critical in the prognosis, diagnosis, and therapy of many illnesses. The market is attributed to growth due to the rising demand for genetic testing and screening to discover disease-related genetic variants. The rapidly developing high-throughput sequencing technology has also spurred the demand for genotyping tests. The rising availability of genetic data and the requirement for large-scale genotyping investigations have fueled market expansion.

Genotyping tests are increasingly adopted in pharmacogenomics to analyze the effect of reactions of medications on a person’s genetic composition. In medication research and clinical trials, the use of genotyping tests helps to identify genetic markers that are linked with therapeutic effectiveness, toxicity, and dose needs. The use of genotyping tests in medication discovery and development procedures further aids market expansion.

Additionally, The growing need for genotyping assays has been spurred by the expansion of research and development efforts in genomics, genetics, and personalized medicine. Genotyping assays developed by pharmaceutical businesses, academic institutions, and biotechnology enterprises are used for biomarker discovery and investigation of genetic variants and genetic connections with diseases. The demand for effective and reliable genotyping tests to assist research efforts drives market expansion.

However, Genotyping assays are expensive when using high-throughput methods like next-generation sequencing (NGS). The reagents, equipment, and data processing costs further limit the accessibility of genotyping tests, especially in resource-constrained settings and smaller research and clinical laboratories. The high cost of genotyping tests is anticipated limit market expansion and prevent extensive use of the method. Additionally, legal and ethical concerns regarding privacy and protection of individual genetic information and potential or unauthorized misuse of the genetic data are other factors that are attributed to impact the market growth negatively.

Global Genotyping Assay MarketSegmentation Analysis

The Global Genotyping Assay Market is Segmented on the basis of Product And Service, Technology, End-Use, And Geography.

Genotyping Assay Market, By Product And Service

• Reagents And Kits
• Genotyping Services
• Instruments
• Bioinformatics

Based on Product And Service, the market is bifurcated into reagents and Reagents And Kits, Genotyping Services, Instruments, and Bioinformatics. The Reagents And Kits segment had the highest share of the market in 2022. The use of specific kits and reagents for various genotyping assays is a key factor driving the market’s growth. The reagents and kits used in the genotyping assays are specific to the procedures for which they are used. For instance, DNA Extraction Kits are used to extract DNA from samples such as tissue, blood, etc.

Genotyping Assay Market, By Technology

• Microarrays
• Polymerase Chain Reaction
• Sequencing
• Capillary Electrophoresis
• Matrix-assisted Laser Desorption or Ionization-Time of Flight Mass Spectrometry

Based on Technology, the market is bifurcated into Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, and Matrix-assisted Laser Desorption or Ionization-Time of Flight Mass Spectrometry. The Polymerase Chain Reaction segment accounted for the largest market share in 2022. The segment growth is due to the wide applications of the procedure for genotyping, DNA amplification, DNA sequencing, gene expression analysis, site-directed mutagenesis, and cloning. The procedure also offers several advantages, such as versatility, speed and efficiency, high sensitivity, and sample requirement.

Genotyping Assay Market, By End-Use

• Pharmacogenomics
• Personalized Medicine and Diagnostics
• Animal Genetics
• Agricultural Biotechnology
• Research and Diagnostic Laboratories
• Academic Institutes

Based on End-Use, the market is bifurcated into Pharmacogenomics, Personalized Medicine and Diagnostics, Animal Genetics, Agricultural Biotechnology. Research and Diagnostic Laboratories, And Academic Institutes. The Research and Diagnostic Laboratories segment had the largest market share in 2022. Factors such as growing funding provided by public and private institutions for research and development are crucial factors driving the segment’s growth. Additionally, growing public and private partnerships undertaken to develop novel technologies to diagnose and treat genetic conditions effectively are expected to drive market growth.

Genotyping Assay Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Genotyping Assay Market is divided into 4 regions which are North America, Europe, Asia Pacific, and the rest of the world. North America held the highest share in 2022. The presence of technologically advanced research infrastructure and key players such as Valero Energy Corporation, Abengoa Bioenergy S.A., Petrobras, and Green Plains in the region is attributed to driving the segment growth. Despite this, Asia Pacific is anticipated to grow lucratively due to the increasing initiatives undertaken by the governments to improve the infrastructure in the region.

Key Players

The “Global Genotyping Assay Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Roche Diagnostics Limited, Thermo Fisher Scientific Inc., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories Inc., Illumina Inc., Agilent Technologies, Eurofins Scientific, GE Healthcare, Pacific Biosciences of California.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In January 2023, Thermo Fisher Scientific announced the launch of CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. The kit is based on Sangers sequencing-based assay, which examines positive HIV samples for genetic variants that resist common antiretroviral therapeutics.
• In August 2022, Bio-Rad Laboratories announced it had acquired Curiosity Diagnostics. The acquisition will help the company to drive innovations in the molecular diagnostics market.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Genotyping Assay Market. We cover the major impacting factors responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Genotyping Assay Market, gauge the attractiveness of a certain sector, and assess investment possibilities.